| 영문 | tuberculosis | 한글 | 결핵 |
|---|---|---|---|
| 설명 | 결핵균에 의한 사람이나 동물의 감염으로서, 결절형성과 조직의 치즈괴사(caseation necrosis)가 특징이다. 주된 원인균은 Mycobacterium tuberculosis, M. bovis, M. avium, M. kansasii와 기타 분류되지 않은 비전형의 미코박테륨도 원인균이 된다. 전형적인 질병과는 임상적으로도 형태학적으로도 구별할 수 없는 비정형감염은, 사람에서 사람으로 직접 감염을 일으키는 것으로 생각되지 않는다. 결핵증은 그 증상의 발현에 있어 대단히 다양하며 만성화되기 쉽다. 모든 장기에 감염이 일어나지만, 사람에 있어서는 주로 폐가 침범되며, 그곳으로부터 혈관과 림프관을 통해 다른 장기에 감염된다. 증상은 오후의 미열과 수면중의 가벼운 식은 땀 등과 함께 침범된 장기의 기능 저하에 따른 증상이 동반된다. 치료는 항결핵제의 장기간, 집중적인 투여이며 필요에 따라서는 수술을 하기도 한다. |
||
| 영문 | Mycobacterium tuberculosis | 한글 | 결핵균 |
|---|---|---|---|
| 설명 | 미코박테륨속의 사람 결핵을 일으키는 균이다. 1882년 코흐(Koch)에 의해 발견되었다. 그램양성 산소성 막대균이며 0.3~0.6×2~4μm, 무아포, 항산성이다. 항산, 항알칼리, 항알코올, 소독제에 저항한다. 저항력과 번식력이 강하여 전염성이 높으나 건조, 열, 햇빛에는 약하다. 세포벽에는 다량의 지방질이 포함되어 있다. 니아신검사는 사람형 결핵균만 양성이며 이것은 감별에 도움이 된다. 감염은 비말감염이고 폐결핵이 많지만 혈행 속에 들어가면 모든 장기에 결핵을 일으킨다. 특유한 결핵결절을 형성한다. 결핵의 진단에는 트베르쿨린 반응이 사용되며 예방에는 비씨지(BCG) 접종이 실시된다. 면역은 세포성 면역이며 큰포식세포의 활성화로 인해 균의 증식이 억제된다. |
||
| AFB | Acid-Fast Bacillus(Type that causes Tuberculosis) |
|---|---|
| NTA | 1) Naso-Tracheal Aspiration 2) National Tuberculosis Association |
| NTM | Non-Tuberculosis Mycobacteria |
| TB, Tb | TuBerculosis; 결핵 = Tbc ? CIX of Op 1. Pulm... |
| Tbc | Tuberculosis = TB, Tb |
| M. tuberculosis | Mycobacterium tuberculosis |
|---|---|
| EBTB | Endobronchial tuberculosis |
| EPTB | Extrapulmonary tuberculosis |
| IUATLD | International Union Against Tuberculosis and Lung Disease |
| MTB | M tuberculosis |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
|---|---|
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
| malaria vaccines | Vaccines made from antigens arising from any of the four strains of plasmodium which cause malaria in humans, or from p. Berghei which causes malaria in rodents. (12 Dec 1998) |
| viral hepatitis vaccines | Any vaccine raised against any virus or viral derivative that causes hepatitis. (12 Dec 1998) |
| viral vaccines | Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. (12 Dec 1998) |
| rickettsial vaccines | Vaccines for the prevention of diseases caused by various species of rickettsia. (12 Dec 1998) |
| poliomyelitis vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
Synonyms : Vaccines, Tuberculosis
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|